Dose Confirmation Study of Cotara for the Treatment of Glioblastoma Multiforme at First Relapse

PHASE2CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

September 30, 2011

Study Completion Date

November 30, 2011

Conditions
Glioblastoma Multiforme
Interventions
DRUG

131I-chTNT-1/B MAb (Cotara)

Given as a single interstitial infusion over approximately 25 hours at a dose of 2.5 mCi/cc.

Trial Locations (7)

19104

University of Pennsylvania, Department of Neurosurgery, Philadelphia

29425

Medical University of South Carolina, Charleston

85013

Barrow Neurological Institute, Phoenix

110029

All India Instutite of Medical Sciences, New Delhi

682026

Amrita Institute of Medical Sciences and Research Center,, Kochi

560 017

Manipal Institute for Neurological Disorders,, Bangalore

Unknown

Department of Neurosurgery Jaslok Hospital and Research Centre, Mumbai

Sponsors
All Listed Sponsors
lead

Peregrine Pharmaceuticals

INDUSTRY